SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is surging following blowout quarterly results, featuring a massive beat on top and bottom-line figures driven by exceptional growth in U.S. commercial revenue. The community is actively celebrating the company's raised forward guidance, with bulls heavily targeting short sellers and speculating on a potential sustained rally toward higher price levels.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc is trending as investors weigh strong expectations for upcoming earnings against persistent concerns over the company's long-term growth and leadership, with the community actively debating whether upcoming AI and AR initiatives can justify a turnaround. While bulls highlight improving advertising momentum and potential upside from AI-powered ad tools, bears remain skeptical of the stock's performance, citing ongoing management criticism and a history of volatility.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following the announcement of a debt-for-equity exchange involving a $1.4 billion debt reduction, a move sparking heated debate among investors regarding the balance between improved financial flexibility and immediate share dilution. While some community members view the move as a strategic cleanup of the balance sheet in preparation for potential acquisitions, others are expressing frustration over the persistent share price pressure and questioning the leadership's long-term capital allocation strategy.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the official UAE approval of ANKTIVA for bladder and lung cancer indications, which is being viewed by the community as a significant step in the company's global expansion. Investors are actively discussing the potential for a larger, imminent partnership announcement and are closely watching upcoming quarterly earnings as a critical catalyst to pressure the stock's high short interest.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing heightened investor attention as the community weighs recent leadership appointments, strategic partnerships, and defense-sector traction against broader market volatility and SPAC-related skepticism. Long-term investors are actively accumulating shares on dips, citing the company's solid balance sheet and technical milestones, while debates persist over the impact of future share lockup expirations and the timing of a commercial quantum breakthrough.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies is experiencing a surge in trading activity following a stellar earnings report that beat revenue expectations, bolstered by a record backlog and significant new government contracts in the defense and space infrastructure sectors. The community is actively discussing the stock's growth potential versus its ongoing path to profitability, with many investors closely monitoring whether the company can successfully scale its operations to meet this accelerating demand.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is seeing heightened activity as the community anticipates the upcoming 80th event data from the Phase 3 REGAL trial, with investors actively debating potential buyout rumors and clinical milestones. The stock is drawing intense focus from both long-term bulls and short-sellers who are closely tracking institutional ownership shifts and market structure signals, such as limited option expirations, while waiting for a major catalyst.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is at the center of investor focus as the market awaits its upcoming quarterly earnings report, with sentiment currently driven by a mix of analyst upgrades and debates over the company's long-term profitability goals. Community discussion is intensely focused on the potential impact of new AI-integrated features, recent subscription price adjustments, and whether the stock's recent price action signals a sustainable breakout or a looming pullback ahead of the earnings release.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is surging following the announcement of a five-year, multi-exabyte storage agreement valued at $335 million with CoreWeave, which has significantly bolstered investor sentiment around its role in AI infrastructure. The community is actively debating whether this deal signals a long-term re-rating for the stock or if it sets the stage for a potential equity offering to fund growth.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is experiencing downward price pressure as investors express frustration over a lack of major updates regarding the COVID-19-Influenza Combination (CIC) program and silence from management ahead of upcoming earnings. While the community remains divided between those betting on the long-term potential of the Matrix-M adjuvant platform and those skeptical of current leadership, intense discussion continues regarding institutional ownership levels and the possibility of future strategic partnerships.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SLS Stock Eyes Green Start To August After Nearly $6M In Fresh Institutional Buying: Retail Stays Bearish

SLS is moving higher on renewed institutional buying, with recent SEC filings showing Opus Capital and Daiwa Securities boosting their stakes by a combined roughly $5.7 million during the quarter. The move also comes as the company's Phase 3 REGAL trial in AML approaches its final analysis, having reached 78 of the 80 required events, and as broader sector M&A speculation around a potential AstraZeneca-Bristol Myers merger has refocused attention on oncology-focused biotechs.

SLS Stock Eyes Green Start To August After Nearly $6M In Fresh Institutional Buying: Retail Stays Bearish 

Equity

Opus Capital held 385,604 shares worth about $5.69 million after increasing its position by 11.3%.

Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure?

A potential AstraZeneca-Bristol Myers deal worth $400 billion would create one of the world’s largest drugmakers and combine major cancer franchises.

SLS Stock In Spotlight After Vanguard Capital Discloses 5.19% Stake – Retail Calls It ‘Huge Vote Of Conviction’ As AML Trial Readout Nears

A new Schedule 13G filing showed Vanguard Capital Management owned 9.67 million SLS shares as of June 30, 2026.

SLS Stock Turns Green After 3-Day Rout: Five Investors Add Shares As Key AML Trial Nears Final Trigger 

New York State Common Retirement Fund boosted its holding by 70%, while Commonwealth and Axxcess each raised stakes by about 17%.

SLS Stock Heads For Worst Month In Over 2 Years — But Retail Bulls ‘Hold’ For AML Readout And Buyout Hopes

An arbitrator recently dismissed Sellas’ claims against 3D Medicines and ordered about $1 million in legal-cost payments.

Nasdaq, S&P 500 Futures Slip As Korea Chip Shock Dents AI Memory Heavyweights Ahead Of Fed Decision: Why NVDA, SNDK, MU, APLD, SPCX, SLS, CAPR Are In Focus

Retail sentiment remains ‘bearish’ on SPY and deteriorated to ‘extremely bearish’ on QQQ, amid growing anxiety around technology stocks.


SLS Stock Hits 1-Month Low On China Arbitration Blow — Retail Bulls Call It A ‘Nothingburger’ Ahead Of AML Readout 

Sellas estimated cash and cash equivalents of $138.3 million as of June 30.

SLS Stock Climbs Premarket: Here’s What Smart Money Is Doing As Sellas Nears Critical Phase 3 AML Readout

CEO Angelos Stergiou said recently on “FOX & Friends” that AI and precision medicine could speed drug development and improve patient selection.

Sellas CEO Angelos Stergiou Says ‘100% Certain’ AI Can Be Used To Beat Cancer 

public companies

During an interview on Fox & Friends on Friday, Stergiou said AI will play a major role in helping cure cancer by enabling more precise treatments.

Nasdaq, S&P 500 Futures Mixed As Oil Surge, Trump Tariffs Cloud Market Outlook: Why INTC, TSLA, SPCX, ORCL, SLS Are In Focus 

Stocktwits data showed retail sentiment is weak, with a shift toward ‘extremely bearish’ on SPY and QQQ.

Neutral Sentiment

$TMDX

$SLS

Which of these trending stocks are you most tempted to buy - $ON, $TMDX, $SLS, or $BE?

Stocktwits

ON Semiconductor Corp.

Transmedics Group Inc

Bloom Energy Corp - Ordinary Shares - Class A

Which of these trending stocks are you most tempted to buy - 

Stocktwits Polls

Investors are on high alert for the anticipated 80th clinical trial event, speculating that results could trigger a major buyout or share price explosion.

Bulls are aggressively betting on a short squeeze as heavy call volume and suspected warrant exhaustion put pressure on trapped shorts to cover.

Community discussions are fixated on the official company quiet period, with many interpreting the lack of recent updates as a sign of imminent news or merger talks.

A growing band of long-term supporters, identifying as 'Rope Hats', are rallying against bearish sentiment and FUD spreaders on the board.

Feed

News

Sentiment

Earnings

Fundamentals

Info